Phase IB study of gene-mediated cytotoxic immunotherapy adjuvant to up-front surgery and intensive timing radiation for malignant glioma.
about
Immunotherapy for cancer in the central nervous system: Current and future directionsSui generis: gene therapy and delivery systems for the treatment of glioblastomaImmunotherapy for primary brain tumors: no longer a matter of privilegeAn update on vaccine therapy and other immunotherapeutic approaches for glioblastomaProgress and problems with the use of suicide genes for targeted cancer therapyCurrent clinical trials testing the combination of immunotherapy with radiotherapy.Stem cells' guided gene therapy of cancer: New frontier in personalized and targeted therapy.Evolution of malignant glioma treatment: from chemotherapy to vaccines to viruses.Marmosets as a preclinical model for testing "off-label" use of doxycycline to turn on Flt3L expression from high-capacity adenovirus vectors.Adenoviral vector-mediated gene therapy for gliomas: coming of age.Current status of gene therapy for brain tumors.Prognostic utility of gene therapy with herpes simplex virus thymidine kinase for patients with high-grade malignant gliomas: a systematic review and meta analysis.Pharmacokinetic study of neural stem cell-based cell carrier for oncolytic virotherapy: targeted delivery of the therapeutic payload in an orthotopic brain tumor model.Gene therapy-mediated reprogramming tumor infiltrating T cells using IL-2 and inhibiting NF-κB signaling improves the efficacy of immunotherapy in a brain cancer modelThe art of gene therapy for glioma: a review of the challenging road to the bedsideOncolytic virotherapy for malignant glioma: translating laboratory insights into clinical practice.Safety profile, efficacy, and biodistribution of a bicistronic high-capacity adenovirus vector encoding a combined immunostimulation and cytotoxic gene therapy as a prelude to a phase I clinical trial for glioblastomaIntraprostatic distribution and long-term follow-up after AdV-tk immunotherapy as neoadjuvant to surgery in patients with prostate cancer.Switching a replication-defective adenoviral vector into a replication-competent, oncolytic adenovirus.Glioma virus therapies between bench and bedside.Temozolomide does not impair gene therapy-mediated antitumor immunity in syngeneic brain tumor models.Effectiveness and preclinical safety profile of doxycycline to be used "off-label" to induce therapeutic transgene expression in a phase I clinical trial for gliomaThe spectrum of vaccine therapies for patients with glioblastoma multiformeCurrent status of immunotherapy and gene therapy for high-grade gliomas.Progress in gene therapy for neurological disorders.Devices for cell transplantation into the central nervous system: Design considerations and emerging technologies.Clinical trials of viral therapy for malignant gliomas.Gene-directed enzyme prodrug therapy.Stem cell in alternative treatments for brain tumors: potential for gene delivery.Combining Oncolytic Adenovirus with Radiation-A Paradigm for the Future of Radiosensitization.Dendritic cell vaccination for glioblastoma multiforme: review with focus on predictive factors for treatment response.Phase II multicenter study of gene-mediated cytotoxic immunotherapy as adjuvant to surgical resection for newly diagnosed malignant gliomaImmunological effects of chemotherapy and radiotherapy against brain tumors.Enzyme/Prodrug Systems for Cancer Gene Therapy.Immune and viral therapies for malignant primary brain tumors.Integration of adenovirus thymidine kinase suicide-gene therapy with surgery and radiation therapy for malignant glioma.Gene-mediated cytotoxic immunotherapy as adjuvant to surgery or chemoradiation for pancreatic adenocarcinoma.A slow-release fibrin matrix increases adeno-associated virus transduction of wound repair cells in vivo.Technical Pitfalls of Signal Truncation in Perfusion MRI of Glioblastoma.Oncolytic virotherapy for gliomas: steps toward the future.
P2860
Q26750765-66E009A8-A573-45F6-BD5E-955AD520737FQ26850467-54424C0B-D4F1-450D-B02C-D90982D34969Q27002510-4326B727-8937-4259-9E44-FE6A2F5F8D3FQ27024830-C095ECE6-03E4-4618-B15F-B72D4CB556B4Q28262370-D8EA5A11-34A1-49EF-AAB5-AF8F3A892602Q30356447-0330E86C-3ADE-4E7B-8E98-026F0D3E29D7Q33653485-A1D583E5-69B2-4BF2-883A-4959C8B577FCQ33923950-C6352B34-95DF-45C4-9493-FEF6DD1C6A5BQ33950709-32A565A0-EC04-4352-9EA3-2B10AA06B142Q34022048-FE68B6B0-F19B-4F70-B25B-D3D248384B72Q34318157-F4E213E2-85B3-45AC-BD36-B42FBD0AB395Q35155376-B527A9D5-14B4-4758-BD91-C6C3DED2C014Q35973436-2A8629C3-DBCA-41B8-AB24-1B74FFAA2BF9Q36345439-A72C7B07-1BBC-4D99-86A7-38DB042C93B5Q36527593-96F990E5-1577-4C17-A475-8FD2AC6809FEQ36634430-E671914B-D247-40E2-80E8-B8BC97F4586CQ36811505-86046C24-C0AA-48E8-817A-741A5BE8A998Q37347492-76434672-FE75-4537-AFD8-19185445EA2EQ37547783-2A4E93D2-F223-4C27-8904-CF56DFF88613Q37580510-C0A8E658-77EE-4CB8-A633-8ABA90A117EAQ37647868-D8AC63F3-831F-4F80-BC04-84D37520E424Q37730116-C6A6BBF7-B563-46DC-B3E6-FF89CB112CB5Q38035788-CDC018C5-7AE1-4A2D-826E-04392A0D7845Q38072814-095DB777-C39F-4DE0-9D9D-485709DE8232Q38100997-DA0F37FB-A2CD-45D3-8178-4B4A3B2EA5F6Q38105080-39145283-07C0-4C39-9E93-7BB98AB2C213Q38153777-137F799D-EFCC-4705-B104-39E832A5D8BAQ38262019-770F9B61-BE4B-4BA9-9D96-0BFC747B2005Q38521752-0EEC87BD-3D3D-4892-BE78-E4A10D9FDCB0Q38645128-47BC732D-5486-4222-B9BD-01AAE5B795DDQ38912265-CA579A3F-D595-44CE-9F62-F14BD14D5622Q38912327-6353702F-5D36-42B5-B51C-4E71F486A214Q38947116-C3E2049D-4FE8-4094-8EB9-56408843ED55Q39064497-0B7B688B-C66F-44A2-9047-D5E5B3C1A002Q39168899-1F6C7BC8-E6FD-4FCB-9E6B-29414B75FD11Q39678222-79FD4814-21C6-4995-B237-23048EBB057BQ42153454-7BAFE32C-8767-4B63-9BEC-B4FBA6E7CCD3Q42259507-AA0A25CC-4C09-496C-BC07-288EDBCB138FQ42386456-F183E7BB-24AB-48C3-BA0A-59121180B26BQ43436260-D8641B53-1C78-4F22-9DC2-0ECA017823D6
P2860
Phase IB study of gene-mediated cytotoxic immunotherapy adjuvant to up-front surgery and intensive timing radiation for malignant glioma.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Phase IB study of gene-mediate ...... adiation for malignant glioma.
@ast
Phase IB study of gene-mediate ...... adiation for malignant glioma.
@en
Phase IB study of gene-mediate ...... adiation for malignant glioma.
@nl
type
label
Phase IB study of gene-mediate ...... adiation for malignant glioma.
@ast
Phase IB study of gene-mediate ...... adiation for malignant glioma.
@en
Phase IB study of gene-mediate ...... adiation for malignant glioma.
@nl
prefLabel
Phase IB study of gene-mediate ...... adiation for malignant glioma.
@ast
Phase IB study of gene-mediate ...... adiation for malignant glioma.
@en
Phase IB study of gene-mediate ...... adiation for malignant glioma.
@nl
P2093
P2860
P356
P1476
Phase IB study of gene-mediate ...... adiation for malignant glioma.
@en
P2093
Abhik Ray-Chaudhuri
Andrea G Manzanera
Arnab Chakravarti
Balveen Kaur
Carissa Monterroso
David S Baskin
E Antonio Chiocca
Estuardo Aguilar-Cordova
Herbert Newton
Jayson Hardcastle
P2860
P304
P356
10.1200/JCO.2011.35.5222
P407
P577
2011-08-15T00:00:00Z